Published on:

Drug Company Trained Sellers to Ignore Drug Risks

Eli Lilly & Co reportedly trained sales people to downplay the risks associated with the drug Zyprexa and to promote its use beyond the approved treatments for schizophrenia and bipolar disorder. The drug, which is linked to weight gain and diabetes, was pushed to primary-care and nursing home doctors with no regard to the risks. Read more here.